What are the top competitors of Zimmer Biomet Holdings, Inc. in Healthcare sector?

The top competitors of Zimmer Biomet Holdings, Inc. in the Healthcare sector are: Abbott Laboratories (ABT.SW), Sonova Holding AG (SOON.SW), Medacta Group S.A. (MOVE.SW), Medartis Holding AG (MED.SW).

Which has better valuations & earnings, Zimmer Biomet Holdings, Inc. or its competitors?

Zimmer Biomet Holdings, Inc. has a market cap of 13.2B and a Dividend Yield of 1.13% compared to its competitors.

Which stock is more profitable: Zimmer Biomet Holdings, Inc. or its competitors?

Zimmer Biomet Holdings, Inc. has an EPS of CHF2.79, while ABT.SW has an EPS of CHF2.95. So, Zimmer Biomet Holdings, Inc. is more profitable compared to ABT.SW.

What is Zimmer Biomet Holdings, Inc. stock volatility and risk in terms of investment?

Zimmer Biomet Holdings, Inc. has daily volatility of 0% as compared to its competitor ABT.SW which is 1.76%. Zimmer Biomet Holdings, Inc. is less volatile as compared to competitors and has low risk.

Is Zimmer Biomet Holdings, Inc. stock profitable?

Zimmer Biomet Holdings, Inc. has a Return on Equity (ROE) of 0.06%. So, Zimmer Biomet Holdings, Inc. is more profitable.

What is Zimmer Biomet Holdings, Inc. stock’s 52 weeks high and low?

Zimmer Biomet Holdings, Inc. stock has a 52-week high of (CHF119) and a low of (CHF67.5).

What was the average volume of Zimmer Biomet Holdings, Inc. stock?

The average volume of Zimmer Biomet Holdings, Inc. is (3) in terms of investment.

Zimmer Biomet Holdings, Inc. (ZBH.SW) Competitors

Zimmer Biomet Holdings, Inc. (ZBH.SW) Stock Competitors & Peer Comparison

See (ZBH.SW) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Devices Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

Symbol	Price	Change %	Market Cap	P/E Ratio	EPS	Dividend Yield
ZBH.SW	CHF 67.50	-4.26%	13.2B	24.19	CHF 2.79	+1.13%
ABT.SW	CHF 84.50	-3.98%	146.8B	28.64	CHF 2.95	+2.29%
SOON.SW	CHF 178.85	-0.08%	10.7B	20.56	CHF 8.70	+2.46%
MOVE.SW	CHF 154.20	+3.07%	3.1B	35.29	CHF 4.37	+0.45%
MED.SW	CHF 80.40	+4.69%	999.6M	120.00	CHF 0.67	N/A

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

ZBH.SW vs ABT.SW Comparison April 2026

ZBH.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ZBH.SW stands at 13.2B. In comparison, ABT.SW has a market cap of 146.8B. Regarding current trading prices, ZBH.SW is priced at CHF 67.50, while ABT.SW trades at CHF 84.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ZBH.SW currently has a P/E ratio of 24.19, whereas ABT.SW's P/E ratio is 28.64. In terms of profitability, ZBH.SW's ROE is +0.06%, compared to ABT.SW's ROE of +0.13%. Regarding short-term risk, ZBH.SW is less volatile compared to ABT.SW. This indicates potentially lower risk in terms of short-term price fluctuations for ZBH.SW.Check ABT.SW's competition here

Zimmer Biomet Holdings, Inc.